Lung Cancer Trial, Recruiting NCT07541521 Sponsor: Shanghai Chest Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07541521
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You are able to carry out daily activities with little or no limitation, or with some restriction but still able to care for yourself (confirm with trial site)
  • Your lung cancer has been confirmed by a tissue sample (biopsy)
  • Your lung cancer is at a mid-to-advanced local stage (stage IIB to III) with no spread to distant parts of the body, and a specialist team has agreed it can be removed or potentially removed by surgery
  • You are planned to receive a combination treatment before surgery that includes both chemotherapy and an immunotherapy drug (a PD-1 or PD-L1 inhibitor); additional radiotherapy to the chest before surgery is also permitted
  • You are planned to have a specific type of lung surgery called a robotic-assisted sleeve lobectomy, along with removal of nearby lymph nodes
  • You have had or are planned to have required scans (such as CT and/or PET-CT) before and after pre-surgery treatment
  • You are able to complete a follow-up visit 30 days after your operation
  • You are able to understand and sign a consent form agreeing to take part

Who may not be able to join:

  • Your cancer has spread to other parts of the body (stage M1), either at the start or after pre-surgery treatment
  • Your pre-surgery treatment plan does not include an immunotherapy drug (chemotherapy alone)
  • You have already received chemotherapy, immunotherapy, or radiotherapy to the chest for this cancer before starting the combined pre-surgery treatment
  • Your surgery is planned only as palliative (to manage symptoms rather than to cure), or only a small, limited removal of tissue is planned when a more complete surgery would normally be recommended
  • After pre-surgery treatment, scans show the cancer is clearly not removable, or the specialist team agrees surgery should not go ahead
  • You have a medical reason that makes general anaesthetic unsafe, or your heart or lung health makes the planned surgery too risky
  • You have an active autoimmune condition that has needed medication to suppress your immune system within the last 2 years, you have previously had an organ transplant, or you have a history of moderate or severe lung inflammation (confirm with trial site)
  • You have an uncontrolled infection, are pregnant or breastfeeding, or have another ongoing illness that could affect your ability to safely take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Chest Hospital
Registry
ClinicalTrials.gov
Start date
13 April 2026
Est. completion
30 May 2027

Where this trial is recruiting

🇨🇳 China 🇫🇷 France 🇮🇹 Italy

Primary endpoints

Unsuccessful RATS Sleeve Lobectomy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov